Research and Markets (http://www.researchandmarkets.com/research/g8c6b4/global_bipolar) has announced the addition of the "Global Bipolar Disorder Epidemiology and Patient Flow Analysis - 2016" report to their offering.

The report provides insights into Bipolar Disorder epidemiology, Bipolar Disorder diagnosed patients, and Bipolar Disorder treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Bipolar Disorder derived from epidemiological analysis, percentage of patients diagnosed with Bipolar Disorder, and percentage of patients treated with Bipolar Disorder therapy.

The study helps executives estimate Bipolar Disorder market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Bipolar Disorder prevalence, Bipolar Disorder diagnosis rate, and Bipolar Disorder treatment rate for the period 2015 - 2022. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

Key Features of the Report:

  • Bipolar Disorder: Disease Definition
  • Bipolar Disorder Patient Flow
  • Bipolar Disorder Prevalence
  • Bipolar Disorder Diagnosed Patients
  • Bipolar Disorder Treated Patients

Key Topics Covered:

1. Bipolar Disorder: Disease Definition

2. Global Bipolar Disorder Patient Flow

3. Bipolar Disorder Patient Flow in the US

4. Bipolar Disorder Patient Flow in Europe

5. Bipolar Disorder Patient Flow in Germany

6. Bipolar Disorder Patient Flow in France

7. Bipolar Disorder Patient Flow in Spain

8. Bipolar Disorder Patient Flow in Italy

9. Bipolar Disorder Patient Flow in UK

10. Bipolar Disorder Patient Flow in Japan

11. Appendix

For more information visit http://www.researchandmarkets.com/research/g8c6b4/global_bipolar